67 related articles for article (PubMed ID: 12395934)
21. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
[TBL] [Abstract][Full Text] [Related]
22. [Exploitation of expression profiles: examples in oncology].
Galiègue S; Casellas P
J Soc Biol; 2002; 196(4):313-5. PubMed ID: 12645302
[TBL] [Abstract][Full Text] [Related]
23. High-throughput biochemical kinase selectivity assays: panel development and screening applications.
Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ
J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965
[TBL] [Abstract][Full Text] [Related]
24. Full automation and validation of a flexible ELISA platform for host cell protein and protein A impurity detection in biopharmaceuticals.
Rey G; Wendeler MW
J Pharm Biomed Anal; 2012 Nov; 70():580-6. PubMed ID: 22727805
[TBL] [Abstract][Full Text] [Related]
25. [Screening marine resources to find novel chemical inhibitors of disease-relevant protein kinases].
Baratte B; Serive B; Bach S
Med Sci (Paris); 2015 May; 31(5):538-45. PubMed ID: 26059305
[TBL] [Abstract][Full Text] [Related]
26. Focus issue: choreographing the dance of the mitotic kinases.
Gough NR
Sci Signal; 2011 Jun; 4(179):eg5. PubMed ID: 21712543
[TBL] [Abstract][Full Text] [Related]
27. The current status of drug discovery against the human kinome.
Eglen RM; Reisine T
Assay Drug Dev Technol; 2009 Feb; 7(1):22-43. PubMed ID: 19382888
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase antagonists: interim challenges and issues.
Sausville EA
Anticancer Drug Des; 2000 Feb; 15(1):1-2. PubMed ID: 10888031
[No Abstract] [Full Text] [Related]
29. Drug efficacy testing in mice.
Kim WY; Sharpless NE
Curr Top Microbiol Immunol; 2012; 355():19-38. PubMed ID: 21823029
[TBL] [Abstract][Full Text] [Related]
30. A solid base for assaying protein kinase activity.
Schlessinger J
Nat Biotechnol; 2002 Mar; 20(3):232-3. PubMed ID: 11875418
[No Abstract] [Full Text] [Related]
31. High-throughput structural biology in drug discovery: protein kinases.
Stout TJ; Foster PG; Matthews DJ
Curr Pharm Des; 2004; 10(10):1069-82. PubMed ID: 15078142
[TBL] [Abstract][Full Text] [Related]
32. Integrated system for the screening of the specificity of protein kinase inhibitors.
Barret JM; Ernould AP; Ferry G; Genton A; Boutin JA
Biochem Pharmacol; 1993 Aug; 46(3):439-48. PubMed ID: 8347167
[TBL] [Abstract][Full Text] [Related]
33. Glycosylation and post-translational modification gene expression analysis by DNA microarrays for cultured mammalian cells.
Brodsky AN; Caldwell M; Harcum SW
Methods; 2012 Mar; 56(3):408-17. PubMed ID: 22033470
[TBL] [Abstract][Full Text] [Related]
34. Protein phosphorylation. Part A. Protein kinases: assays, purification, antibodies, functional analysis, cloning, and expression.
Methods Enzymol; 1991; 200():1-763. PubMed ID: 1956313
[No Abstract] [Full Text] [Related]
35. IPK'2001. Abstracts of the 2nd International Conference on Inhibitors of Protein Kinases and the Workshop on Computer-Aided Drug Design. September 9-15, 2001. Warsaw, Poland.
Cell Mol Biol Lett; 2001; 6(2B):447-565. PubMed ID: 11787496
[No Abstract] [Full Text] [Related]
36. Novel molecular imaging platform for monitoring oncological kinases.
Nyati S; Ross BD; Rehemtulla A; Bhojani MS
Cancer Cell Int; 2010 Jul; 10():23. PubMed ID: 20615241
[TBL] [Abstract][Full Text] [Related]
37. Mechanistic enzymology in drug discovery: a fresh perspective.
Holdgate GA; Meek TD; Grimley RL
Nat Rev Drug Discov; 2018 Feb; 17(2):115-132. PubMed ID: 29192286
[TBL] [Abstract][Full Text] [Related]
38. Marine derived hamacanthins as lead for the development of novel PDGFRβ protein kinase inhibitors.
Pinchuk B; Johannes E; Gul S; Schlosser J; Schaechtele C; Totzke F; Peifer C
Mar Drugs; 2013 Aug; 11(9):3209-23. PubMed ID: 24065162
[TBL] [Abstract][Full Text] [Related]
39. Integrated technology platform protein kinases for drug development in oncology.
Sachsenmaier C; Schächtele C
Biotechniques; 2002 Oct; Suppl():101-6. PubMed ID: 12395934
[TBL] [Abstract][Full Text] [Related]
40. Protein kinases: From targets to anti-cancer drugs.
Cruzalegui F
Ann Pharm Fr; 2010 Jul; 68(4):254-9. PubMed ID: 20637357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
